Key result
Plasma ADMA linked to retinopathy in patients with type 2 diabetes.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support ADMA as retinopathy biomarker in type 2 diabetes; hypothesis-generating and should not yet change practice.
ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine.A table elsewhere in this issue shows conventional and Syste `
No takes yet. Share an insight, caveat, or question.
Małecki et al. (2007) studied this question. Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: